Sirolimus-Eluting Stents: From RESEARCH to Clinical Practice Patrick W. Serruys; Pedro A. Lemos Shipping Calculator Request a Quote for 10+ Copies Tell A Friend More Info... Synopsis Similar Items Customer Reviews Related Subjects Additional Description More titles by Patrick W. Serruys More titles by Pedro A. Lemos Retail Price: $109.95 Cardiotext Price: $107.75 Availability: Processing time varies. Price is tentative. Alert me when this product is available Availability Questions? Product Information: ISBN-13: 9781841844923 ISBN-10: 1841844926 Publisher: CRC Press Format: Hardback, 194 pages Pub Date: 10/2004 Edition Number: 1

---

Synopsis Recently, sirolimus-eluting stents implantation has been shown to decrease restenosis markedly in selected patients. Nonetheless, the effects of SES implantation in complex, unselected patients, such as those commonly treated in daily practice ('the real world'), remains largely unknown. This book comprehensively evaluates the impact of SES implantation on the outcomes of patients treated in the real world of interventional cardiology. The authors have evaluated in detail the short- and long-term outcomes of several high-risk subsets not currently included in randomized trials. While it is specific to sirolimus, the book covers the major competing drug eluting stents, including paclitaxel.

---

Customer Reviews

Be the first to review this product

---

Browse Titles In Related Subjects

• Cardiology (General)
• Stenting

---

Additional Description

Table of Contents
SIROLIMUS-ELUTING STENTS IN THE CLINICAL PRACTICE: CONCEPTS AND GENERAL OVERVIEW
Sirolimus-Eluting Stents as an Anti-Restenosis Device: Basic Concepts and Summary of Pivotal Studies, P.W. Serruys and P.A. Lemos
Sirolimus-Eluting Stents in the "Real World": The RESEARCH Registry Rationale and Study Design, P.A. Lemos, P.W. Serruys, and R.T. van Domburg
Unrestricted Utilization of Sirolimus-Eluting Stents for de Novo Coronary Lesions, P.A. Lemos, P.W. Serruys, and R.T. van Domburg

SIROLIMUS-ELUTING STENTS FOR PATIENTS AT HIGH CLINICAL RISK
Early Safety of Sirolimus-Eluting Stents for Patients with Acute Coronary Syndromes, P.A. Lemos, C-h. Lee, and P.W. Serruys
Sirolimus-Eluting Stents for Patients with Acute Myocardial Infarction, F. Saia, P.A. Lemos, and P.W. Serruys
Sirolimus-Eluting Stents for Patients with Impaired Renal Function, P.A. Lemos, R.T. van Domburg, and P.W. Serruys
Sirolimus-Eluting Stents for Patients with Prior Coronary Bypass Graft Surgery, A. Hoye and P.W. Serruys
Sirolimus-Eluting Stents for Main Left Coronary Artery Disease, C.A. Arampatzis and P.W. Serruys
Sirolimus-Eluting Stents for Patients with Multivessel Coronary Disease, C.A. Arampatzis and P.A. Lemos
Sirolimus-Eluting Stents for Elderlies, M. Vijayakumar, P.A. Lemos, and P.W. Serruys

SIROLIMUS-ELUTING STENTS FOR PATIENTS AT SPECIAL ANATOMIC GROUPS
Sirolimus-Eluting Stents for Chronic Total Occlusions, A. Hoye, K. Tanabe, and P.W. Serruys
Sirolimus-Eluting Stents for Very Small Coronary Vessels, P.A. Lemos and P.W. Serruys
Sirolimus-Eluting Stents for Very Long Lesions, M. Degertekin, C.A. Arampatzis, and P.A. Lemos
Sirolimus-Eluting Stents for Bifurcation Lesions, K. Tanabe, A. Hoye, and P.W. Serruys
Sirolimus-Eluting Stents for Coronary Narrowings